Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
35.3M
-
Shares change
-
+691K
-
Total reported value, excl. options
-
$273M
-
Value change
-
+$6.74M
-
Put/Call ratio
-
0.05
-
Number of buys
-
41
-
Number of sells
-
-37
-
Price
-
$7.72
Significant Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q4 2015
101 filings reported holding LBIO - LION BIOTECHNOLOGIES INC - COM as of Q4 2015.
LION BIOTECHNOLOGIES INC - COM (LBIO) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.3M shares
.
Largest 10 shareholders include FMR LLC (5.72M shares), venBio Select Advisor LLC (3.19M shares), PERCEPTIVE ADVISORS LLC (3M shares), RS INVESTMENT MANAGEMENT CO LLC (2.65M shares), FRANKLIN RESOURCES INC (2.18M shares), Broadfin Capital, LLC (2.11M shares), ACUTA CAPITAL PARTNERS, LLC (1.92M shares), BAKER BROS. ADVISORS LP (1.82M shares), BlackRock Fund Advisors (1.79M shares), and VANGUARD GROUP INC (1.51M shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.